Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News The Cass Report, Evidence, and Ethical Thinking on Pediatric Gender-Affirming Care President of the Bioethics Network of the Upper Midwest (BENUM) A Georgia School Trains Doulas for Rural Areas That Are Losing Maternity Care